Recent Price Movement and Market Context
On the day in question, Deccan Health Care Ltd’s share price marginally increased by 0.36%, yet this was notably below the Sensex’s gain of 1.16%. Over the past five trading sessions, the stock has experienced a consecutive decline, shedding 13.73% in value. This downward trajectory has culminated in the stock trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling persistent bearish momentum.
When compared to the sector, the stock underperformed by 1.42% on the day, underscoring its relative weakness within the Healthcare Services industry. The broader market indices have shown resilience, with the Sensex posting modest gains over various time frames, contrasting sharply with Deccan Health Care’s performance.
Extended Performance Analysis
Deccan Health Care Ltd’s performance over multiple periods reveals a pattern of consistent underperformance. Over one week, the stock declined by 13.02%, while the Sensex rose by 0.68%. The one-month return was a negative 20.67%, more than double the Sensex’s decline of 9.35%. Over three months, the stock fell 29.50%, compared to the Sensex’s 11.61% drop.
Longer-term figures are equally stark. The stock’s one-year return stands at -32.79%, significantly lagging the Sensex’s modest 1.68% loss. Year-to-date, the stock has declined 25.12%, while the Sensex has fallen 11.91%. Over three and five years, the stock has plummeted 59.50% and 64.63% respectively, in contrast to the Sensex’s robust gains of 30.26% and 50.56%. Over a decade, Deccan Health Care Ltd’s stock price has remained flat, while the Sensex surged by over 200%.
Our latest weekly pick is out! This Large Cap from Steel/Sponge Iron/Pig Iron delivered with target price and complete analysis. See what makes this week's selection special!
- - Latest weekly selection
- - Target price delivered
- - Large Cap special pick
Fundamental Assessment and Ratings
Deccan Health Care Ltd currently holds a Mojo Score of 29.0 and has been assigned a Mojo Grade of Strong Sell as of 23 Feb 2026, an upgrade from its previous Sell rating. This grading reflects the company’s weak long-term fundamental strength, highlighted by an average Return on Equity (ROE) of just 1.43%. Such a low ROE indicates limited profitability relative to shareholder equity, a key metric for assessing financial health.
The stock’s micro-cap status further emphasises its relatively small market capitalisation, which can contribute to higher volatility and liquidity concerns. The company’s consistent underperformance against the BSE500 benchmark over the last three annual periods, including a -32.79% return in the past year, reinforces the challenges faced by the stock in delivering shareholder value.
Operational Metrics and Valuation
Despite the negative price trends, Deccan Health Care Ltd has reported positive results for four consecutive quarters. Key operational metrics include an inventory turnover ratio of 1.84 times for the half-year period, indicating the frequency at which inventory is sold and replaced. The company’s quarterly PBDIT peaked at Rs 1.73 crore, while its operating profit to net sales ratio reached a high of 9.95%, suggesting some efficiency in converting sales into operating profit.
Valuation metrics present a mixed picture. The company’s ROE of 1.3% is accompanied by an attractive Price to Book Value ratio of 0.3, signalling that the stock is trading at a discount relative to its book value. This valuation is lower than the average historical valuations of its peers in the Healthcare Services sector. Additionally, the company’s profits have increased by 95.7% over the past year, despite the stock’s negative return of 32.79%. The PEG ratio stands at 0.2, which typically indicates undervaluation relative to earnings growth.
Deccan Health Care Ltd or something better? Our SwitchER feature analyzes this micro-cap Healthcare Services stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Summary of Challenges and Market Position
Deccan Health Care Ltd’s stock has been on a prolonged downward trajectory, culminating in its new all-time low price of Rs.10.99. The stock’s performance has lagged significantly behind both the Sensex and its sector peers across all measured time frames, from one week to ten years. The company’s fundamental indicators, including ROE and market capitalisation, reflect a micro-cap entity with limited profitability and growth prospects as perceived by the market.
While operational results have shown some positive trends in profitability and inventory management, these have not translated into share price appreciation. The valuation metrics suggest the stock is trading at a discount, yet this has not been sufficient to arrest the decline in market value. The Mojo Grade of Strong Sell further underscores the cautious stance adopted by market analysts based on the company’s financial and market data.
Conclusion
Deccan Health Care Ltd’s fall to an all-time low is a significant event within the Healthcare Services sector, reflecting a combination of subdued financial performance and persistent market pressures. The stock’s extended period of underperformance relative to benchmarks and peers highlights the severity of its current market position. Investors and market participants will continue to monitor the company’s financial disclosures and market movements closely as it navigates this challenging phase.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
